Who owns MONTE ROSA THERAPEUTICS INC?
- Ticker: GLUE
- CUSIP Number: 61225m102
Tip: Access positions for across all investors
Analyze quarterly positions in Monte Rosa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Monte Rosa Therapeutics stock
Who bought or sold MONTE ROSA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
NEA Management Company | 7.7M | $44M | 0% | Dec 2023 |
|
FMR | 6.0M | $29M | -8% | Sep 2023 |
|
T. Rowe Price Associates | 4.9M | $28M | 28% | Dec 2023 |
|
Baker Bros. Advisors | 4.9M | $28M | 0% | Dec 2023 |
|
venBio Select Advisor | 4.5M | $26M | 0% | Dec 2023 |
|
BlackRock | 3.7M | $18M | -4% | Sep 2023 |
|
Vanguard Group | 1.6M | $9.0M | -2% | Dec 2023 |
|
Aisling Capital Management | 1.5M | $8.3M | 0% | Dec 2023 |
|
Alphabet | 1.5M | $8.3M | 0% | Dec 2023 |
|
Citadel Advisors | 1.0M | $5.9M | 24% | Dec 2023 |
|
Geode Capital Management | 648k | $3.1M | 6% | Sep 2023 |
|
ExodusPoint Capital Management | 619k | $3.0M | -8% | Sep 2023 |
|
State Street Corporation | 593k | $2.8M | 0% | Sep 2023 |
|
Casdin Capital | 511k | $2.9M | 0% | Dec 2023 |
|
Northern Trust | 444k | $2.1M | 4% | Sep 2023 |
|
Caption Management | 423k | $2.4M | 17% | Dec 2023 |
|
Charles Schwab Investment Management | 246k | $1.4M | 1% | Dec 2023 |
|
TD Asset Management | 193k | $1.1M | 0% | Dec 2023 |
|
Nuveen Asset Management | 154k | $737k | 9% | Sep 2023 |
|
Candriam Luxembourg S.C.A. | 135k | $763k | 0% | Dec 2023 |
|
Manufacturers Life Insurance Company | 105k | $501k | 0% | Sep 2023 |
|
Bank of New York Mellon | 101k | $568k | 7% | Dec 2023 |
|
Ing Investment Management | 93k | $445k | 0% | Sep 2023 |
|
Renaissance Technologies | 92k | $438k | 12% | Sep 2023 |
|
UBS O'Connor | 86k | $409k | -15% | Sep 2023 |
|
Bank of America Corporation | 81k | $456k | -1% | Dec 2023 |
|
Jane Street | 71k | $400k | 100% | Dec 2023 |
|
Millennium Management | 67k | $380k | 100% | Dec 2023 |
|
Sarasin & Partners | 65k | $368k | 0% | Dec 2023 |
|
Hrt Financial | 63k | $357k | 491% | Dec 2023 |
|
Barclays | 61k | $346k | 365% | Dec 2023 |
|
Sphera Funds Management | 49k | $274k | 100% | Dec 2023 |
|
Rhumbline Advisers | 45k | $256k | -1% | Dec 2023 |
|
California State Teachers Retirement System | 44k | $210k | -7% | Sep 2023 |
|
Balyasny Asset Management | 39k | $219k | 100% | Dec 2023 |
|
UBS Group | 38k | $214k | 63% | Dec 2023 |
|
Goldman Sachs Group | 37k | $210k | -31% | Dec 2023 |
|
Morgan Stanley | 36k | $173k | -29% | Sep 2023 |
|
Susquehanna International | 31k | $149k | 43% | Sep 2023 |
|
CornerCap Investment Counsel | 28k | $157k | 0% | Dec 2023 |
|
State of Wisconsin Investment Board | 28k | $157k | -27% | Dec 2023 |
|
Dimensional Fund Advisors | 24k | $137k | -35% | Dec 2023 |
|
Alliancebernstein | 24k | $133k | 0% | Dec 2023 |
|
Exchange Traded Concepts | 23k | $132k | 34% | Dec 2023 |
|
Jpmorgan Chase & Co | 22k | $124k | -25% | Dec 2023 |
|
Legal & General Group | 20k | $114k | -42% | Dec 2023 |
|
Credit Suisse | 20k | $113k | -69% | Dec 2023 |
|
American Century Companies | 20k | $95k | 53% | Sep 2023 |
|
MetLife Investment Advisors | 18k | $103k | 0% | Dec 2023 |
|
Squarepoint Ops | 18k | $99k | 100% | Dec 2023 |
|
Tower Research Capital | 17k | $82k | 929% | Sep 2023 |
|
American International | 15k | $86k | 0% | Dec 2023 |
|
Florida State Board of Administration | 15k | $85k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 14k | $79k | 0% | Dec 2023 |
|
Verition Fund Management | 13k | $63k | 100% | Sep 2023 |
|
SG Americas Securities | 12k | $69k | -12% | Dec 2023 |
|
New York State Common Retirement Fund | 12k | $69k | 0% | Dec 2023 |
|
Mirae Asset Global Investments | 12k | $68k | -9% | Dec 2023 |
|
Wells Fargo & Company | 12k | $67k | 22% | Dec 2023 |
|
Royal Bank of Canada | 11k | $63k | 50% | Dec 2023 |
|
Cubist Systematic Strategies | 11k | $60k | 100% | Dec 2023 |
|
Simplex Trading | 10k | $56k | -62% | Dec 2023 |
|
Point72 Middle East FZE | 9.3k | $53k | 100% | Dec 2023 |
|
Citigroup | 4.4k | $24k | 522% | Dec 2023 |
|
Amalgamated Bank | 2.7k | $15k | -10% | Dec 2023 |
|
Summit Investment Advisors | 2.2k | $13k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.8k | $10k | 0% | Dec 2023 |
|
Advisor Group Holdings | 400.00 | $2.3k | 100% | Dec 2023 |
|
Northwestern Mutual Wealth Management Company | 300.00 | $1.4k | 0% | Sep 2023 |
|
Who sold out of Monte Rosa Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Octagon Capital Advisors | Sep 2023 | 813k | $3.9M |
Swiss National Bank | Sep 2023 | 91k | $437k |
Two Sigma Investments | Sep 2023 | 67k | $320k |
Silverarc Capital Management | Jun 2023 | 31k | $213k |
Trexquant Investment | Sep 2023 | 26k | $123k |
Henderson Group | Sep 2023 | 24k | $114k |
T. Rowe Price Investment Management | Jun 2023 | 21k | $147k |
Connor, Clark & Lunn Investment Management | Sep 2023 | 15k | $70k |
Corton Capital | Sep 2023 | 15k | $69k |
Arizona State Retirement System | Sep 2023 | 12k | $57k |
Teacher Retirement System Of Texas | Sep 2023 | 12k | $57k |
China Universal Asset Management | Sep 2023 | 1.3k | $6.0k |
NISA Investment Advisors | Sep 2023 | 1.2k | $5.6k |